Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Charles G. Mullighan, Salil Goorha, Ina Radtke et al. · Nature · 2007 · 1.8K citations

Life Sciences, Genetics, Molecular Genetics +16

Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia

Charles G. Mullighan, Xiaoping Su, Jinghui Zhang et al. · New England Journal of Medicine · 2009 · 1.4K citations · Full text

Life Sciences, Genetics, Hematology +15

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

Charles G. Mullighan, Christopher B. Miller, Ina Radtke et al. · Nature · 2008 · 1.1K citations

Life Sciences, Genetics, Molecular Genetics +9

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

Monique L. den Boer, Marjon van Slegtenhorst, Renée X. de Menezes et al. · The Lancet Oncology · 2009 · 925 citations · Full text

Medicine, Hematology, Oncology +16

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

Deborah A. Thomas · Blood · 2003 · 569 citations

Medicine, Hematology, Oncology +11